First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens Policy + Initiatives September 24, 2023 …
Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance Biodetection September 19, 2023 …
With Mississippi Declared Endemic Area for Melioidosis Pathogen – Public Health Needs Support to Respond Pathogens September 2, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Treatments for Poxviruses May Already Exist in Licensed Drugs Medical Countermeasures August 9, 2023 …
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
